#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	AAC_2___Ic.3002525.AL123456.3.314308_314854.4719	1	0	27	412	AAC_2___Ic	546	546	100.0	AAC_2___Ic.l15.c17.ctg.1	1096	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	AAC(2')-Ic;b"AAC(2')-Ic is a chromosomal-encoded aminoglycoside acetyltransferase in M. tuberculosis and Mycobacterium tuberculosis variant bovis."
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	C69T	SNP	69	69	C	264	264	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	G72.	DEL	72	72	G	266	266	T	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	T74.	DEL	74	74	T	267	267	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	T77C	SNP	77	77	T	270	270	C	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	G81A	SNP	81	81	G	273	273	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	G83A	SNP	83	83	G	275	275	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	Cutibacterium_acnes_16S.3003499.NR_040847.1.0_1486.3259	0	0	528	24	Cutibacterium_acnes_16S	1486	115	92.17	Cutibacterium_acnes_16S.l15.c30.ctg.1	314	0.0	0	.	n	.	0	G85A	SNP	85	85	G	277	277	A	ND	ND	ND	.	Cutibacterium acnes 16S rRNA mutation conferring resistance to tetracycline
Erm_37_.3000392.AL123456.1.2231679_2232219.582	Erm_37_.3000392.AL123456.1.2231679_2232219.582	1	0	27	284	Erm_37_	540	540	100.0	Erm_37_.l15.c4.ctg.1	948	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Erm(37);b'Erm(37) is found in Mycobacterium species and confers the MLSb phenotype. In addition to methylation of A2058 this Erm methylates adjacent adenosines (A2057 and A2059) as well.'
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2194T	SNP	2194	2194	C	65	65	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	G2301A	SNP	2301	2301	G	172	172	A	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2346T	SNP	2346	2346	C	217	217	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	A2347C	SNP	2347	2347	A	218	218	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2358G	SNP	2358	2358	T	229	229	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	A2361G	SNP	2361	2361	A	232	232	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2362C	SNP	2362	2362	T	233	233	C	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	A2399G	SNP	2399	2399	A	270	270	G	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2402T	SNP	2402	2402	C	273	273	T	ND	ND	ND	.	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159	0	0	528	38	Mycobacterium_intracellulare_23S_1	3103	278	95.68	Mycobacterium_intracellulare_23S_1.l15.c30.ctg.1	279	0.0	1	SNP	n	A2268C	0	.	.	2268	2268	A	139	139	A	ND	ND	ND	Mycobacterium_intracellulare_23S.3004167.NR_076151.1.0_3103.4159:0:0:A2268C:.:b'Point mutation in the 23S rRNA of Mycobaccterium avium shown to confer resistance to azithromycin, a macrolide type antibiotic.'	Mycobacterium intracellulare 23S rRNA with mutation conferring resistance to azithromycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	838	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c30.ctg.1	1686	0.0	1	SNP	p	V219A	0	.	.	655	657	GTC	916	918	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:V219A:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483	1	1	27	838	Mycobacterium_tuberculosis_Rv1258c_1	1260	1260	100.0	Mycobacterium_tuberculosis_Rv1258c_1.l6.c30.ctg.1	1686	0.0	1	SNP	p	S292L	0	.	.	874	876	TCG	1135	1137	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_Rv1258c.3007186.AE000516.2.1405567_1406827.8483:1:1:S292L:.:b'Mutations in the M. tuberculosis efflux pump Rv1258c (Tap) conferring resistance to pyrazinamide, isoniazid, and streptomycin.'	Mycobacterium tuberculosis Rv1258c mutations confer resistance to pyrazinamide, isoniazid, and streptomycin
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	R13C	0	.	.	37	39	CGT	191	193	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R13C:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	V18A	0	.	.	52	54	GTG	206	208	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:V18A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	L50V	0	.	.	148	150	CTG	302	304	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:L50V:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	T110A	0	.	.	328	330	ACC	482	484	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:T110A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	R268H	0	.	.	802	804	CGC	956	958	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:R268H:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	A300P	0	.	.	898	900	GCC	1052	1054	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:A300P:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	G313R	0	.	.	937	939	GGG	1091	1093	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G313R:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726	1	1	27	1012	Mycobacterium_tuberculosis_ndh	1392	1392	100.0	Mycobacterium_tuberculosis_ndh.l15.c4.ctg.1	1741	0.0	1	SNP	p	G339A	0	.	.	1015	1017	GGG	1169	1171	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	Mycobacterium_tuberculosis_ndh.3003461.AL123456.3.2101650_2103042.4726:1:1:G339A:.:b'Point mutations in the Mycobacterium tuberculosis ndh gene shown clinically to confer resistance to isoniazid.'	Mycobacterium tuberculosis ndh with mutation conferring resistance to isoniazid
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	168	98.21	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	292	0.0	0	.	n	.	0	T1419C	SNP	1419	1419	T	83	83	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	168	98.21	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	292	0.0	0	.	n	.	0	T1420G	SNP	1420	1420	T	84	84	G	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	168	98.21	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	292	0.0	1	SNP	n	A1375G	0	.	.	1375	1375	A	39	39	A	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:A1375G:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	168	98.21	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	292	0.0	1	SNP	n	C1376U	0	.	.	1376	1376	C	40	40	C	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:C1376U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	168	98.21	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.1	292	0.0	1	SNP	n	G1458U	0	.	.	1458	1458	G	122	122	G	ND	ND	ND	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256:0:0:G1458U:.:b'Point mutations in the 16S rRNA of Mycobacteroides abscessus conferring resistance to gentamicin.'	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	159	96.27	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	400	0.0	0	.	n	.	0	C69T	SNP	69	69	C	309	309	T	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	159	96.27	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	400	0.0	0	.	n	.	0	.75A	INS	75	75	G	316	316	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	159	96.27	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	400	0.0	0	.	n	.	0	G77A	SNP	77	77	G	318	318	A	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	Mycobacteroides_abscessus_16S.3003240.CU458896.1.1462398_1463901.3256	0	0	512	54	Mycobacteroides_abscessus_16S_4	1504	159	96.27	Mycobacteroides_abscessus_16S_4.l15.c4.ctg.2	400	0.0	0	.	n	.	0	T129C	SNP	129	129	T	370	370	C	ND	ND	ND	.	Mycobacteroides abscessus 16S rRNA mutation conferring resistance to gentamicin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2292C	SNP	2292	2292	T	159	159	C	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	G2294A	SNP	2294	2294	G	161	161	A	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2306T	SNP	2306	2306	C	173	173	T	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2310C	SNP	2310	2310	T	177	177	C	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2314A	SNP	2314	2314	T	181	181	A	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	A2349C	SNP	2349	2349	A	216	216	C	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2352G	SNP	2352	2352	C	219	219	G	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	G2361T	SNP	2361	2361	G	228	228	T	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2364G	SNP	2364	2364	T	231	231	G	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	T2366C	SNP	2366	2366	T	233	233	C	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	A2373G	SNP	2373	2373	A	240	240	G	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2375T	SNP	2375	2375	C	242	242	T	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	A2403G	SNP	2403	2403	A	270	270	G	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	0	.	n	.	0	C2405A	SNP	2405	2405	C	272	272	A	ND	ND	ND	.	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	1	SNP	n	A2271G	0	.	.	2271	2271	A	138	138	A	ND	ND	ND	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156:0:0:A2271G:.:b'Point mutation in the 23S rRNA of Mycobacteroides abscessus shown to confer resistance to clarithromycin, a macrolide type antibiotic.'	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	1	SNP	n	A2272G	0	.	.	2272	2272	A	139	139	A	ND	ND	ND	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156:0:0:A2272G:.:b'Point mutation in the 23S rRNA of Mycobacteroides abscessus shown to confer resistance to clarithromycin, a macrolide type antibiotic.'	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156	0	0	528	26	Mycobacteroides_abscessus_23S	3112	279	92.47	Mycobacteroides_abscessus_23S.l15.c30.ctg.1	279	0.0	1	SNP	n	A2272C	0	.	.	2272	2272	A	139	139	A	ND	ND	ND	Mycobacteroides_abscessus_23S.3004163.NC_010397.1.1464207_1467319.4156:0:0:A2272C:.:b'Point mutation in the 23S rRNA of Mycobacteroides abscessus shown to confer resistance to clarithromycin, a macrolide type antibiotic.'	Mycobacteroides abscessus 23S rRNA with mutation conferring resistance to clarithromycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	125	97.6	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	292	0.0	0	.	n	.	0	T1397C	SNP	1397	1397	T	81	81	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	125	97.6	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	292	0.0	0	.	n	.	0	T1400G	SNP	1400	1400	T	84	84	G	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	125	97.6	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.1	292	0.0	1	SNP	n	A1355G	0	.	.	1355	1355	A	39	39	A	ND	ND	ND	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271:0:0:A1355G:.:b'Point mutations in the 16S rRNA of Mycobacteroides chelonae can cause resistance to neomycin.'	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	139	95.74	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	216	0.0	0	.	n	.	0	.47T	INS	47	47	G	123	123	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	139	95.74	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	216	0.0	0	.	n	.	0	C49T	SNP	49	49	C	125	125	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	139	95.74	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	216	0.0	0	.	n	.	0	G57A	SNP	57	57	G	134	134	A	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	139	95.74	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	216	0.0	0	.	n	.	0	C108T	SNP	108	108	C	185	185	T	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	Mycobacteroides_chelonae_16S.3003518.NR_114659.1.1_1441.3271	0	0	512	42	Mycobacteroides_chelonae_16S_4	1441	139	95.74	Mycobacteroides_chelonae_16S_4.l15.c4.ctg.2	216	0.0	0	.	n	.	0	T109C	SNP	109	109	T	186	186	C	ND	ND	ND	.	Mycobacteroides chelonae 16S rRNA mutation conferring resistance to neomycin
Planobispora_rosea_EF_Tu.3003361.U67308.1.476_1670.3512	Planobispora_rosea_EF_Tu.3003361.U67308.1.476_1670.3512	1	1	528	22	Planobispora_rosea_EF_Tu	1194	113	95.61	Planobispora_rosea_EF_Tu.l15.c4.ctg.1	120	0.0	0	.	p	.	0	E309fs	FSHIFT	925	925	G	30	30	A	ND	ND	ND	.	Planobispora rosea EF-Tu mutants conferring resistance to inhibitor GE2270A
blaC.3007182.AL123456.3.2325885_2326809.8481	blaC.3007182.AL123456.3.2325885_2326809.8481	1	0	27	558	blaC	924	924	100.0	blaC.l6.c17.ctg.1	1295	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	blaC;b'blaC is a broad-spectrum class A beta-lactamase coded in the chromosome of Mycobacterium tuberculosis. It has been shown to hydrolyze a large number of beta-lactam antibiotics and is a major obstacle in the treatment of tuberculosis with such drugs.'
efpA.3003955.AL123456.3.3153038_3154631.5259	efpA.3003955.AL123456.3.3153038_3154631.5259	1	0	27	1032	efpA	1593	1593	100.0	efpA.l15.c4.ctg.1	1990	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	b'efpA is an MFS transporter found in Mycobacterium tuberculosis.';efpA
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	D4N	0	.	.	10	12	GAC	176	178	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D4N:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	G5S	0	.	.	13	15	GGT	179	181	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G5S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	A201T	0	.	.	601	603	GCG	767	769	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A201T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	G321S	0	.	.	961	963	GGC	1127	1129	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G321S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	G350D	0	.	.	1048	1050	GGC	1214	1216	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:G350D:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	A462V	0	.	.	1384	1386	GCG	1550	1552	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:A462V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	D833A	0	.	.	2497	2499	GAC	2663	2665	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:D833A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embA.3003453.CP003248.1.4243410_4246695.2081	embA.3003453.CP003248.1.4243410_4246695.2081	1	1	27	1994	embA	3285	3285	100.0	embA.l15.c4.ctg.1	3565	0.0	1	SNP	p	P913S	0	.	.	2737	2739	CCG	2903	2905	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embA.3003453.CP003248.1.4243410_4246695.2081:1:1:P913S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis embA leading to the lowered affinity of ethambutol to embA.'	Mycobacterium tuberculosis embA mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	L239P	0	.	.	715	717	CTG	980	982	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L239P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D240H	0	.	.	718	720	GAC	983	985	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D240H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	S297A	0	.	.	889	891	TCG	1154	1156	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S297A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D299E	0	.	.	895	897	GAC	1160	1162	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D299E:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	M306T	0	.	.	916	918	ATG	1181	1183	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306T:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	M306I	0	.	.	916	918	ATG	1181	1183	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306I:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	M306V	0	.	.	916	918	ATG	1181	1183	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	M306L	0	.	.	916	918	ATG	1181	1183	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M306L:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D311H	0	.	.	931	933	GAC	1196	1198	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D311H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	Y319N	0	.	.	955	957	TAT	1220	1222	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	Y319C	0	.	.	955	957	TAT	1220	1222	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y319C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D328G	0	.	.	982	984	GAT	1247	1249	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D328Y	0	.	.	982	984	GAT	1247	1249	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D328Y:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	F330V	0	.	.	988	990	TTC	1253	1255	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:F330V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	Y333C	0	.	.	997	999	TAT	1262	1264	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y333C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	Y334H	0	.	.	1000	1002	TAC	1265	1267	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Y334H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	A356V	0	.	.	1066	1068	GCC	1331	1333	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A356V:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	A357S	0	.	.	1069	1071	GCC	1334	1336	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:A357S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	E368A	0	.	.	1102	1104	GAG	1367	1369	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E368A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	P375A	0	.	.	1123	1125	CCG	1388	1390	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P375A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	E378A	0	.	.	1132	1134	GAG	1397	1399	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E378A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	S380R	0	.	.	1138	1140	AGC	1403	1405	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:S380R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	P397Q	0	.	.	1189	1191	CCG	1454	1456	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P397Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	N399H	0	.	.	1195	1197	AAC	1460	1462	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:N399H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	G406A	0	.	.	1216	1218	GGC	1481	1483	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	G406D	0	.	.	1216	1218	GGC	1481	1483	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	G406C	0	.	.	1216	1218	GGC	1481	1483	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	G406S	0	.	.	1216	1218	GGC	1481	1483	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G406S:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	L413P	0	.	.	1237	1239	CTG	1502	1504	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:L413P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	P446H	0	.	.	1336	1338	CCC	1601	1603	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:P446H:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	R460C	0	.	.	1378	1380	CGC	1643	1645	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R460C:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	I465D	0	.	.	1393	1395	ATC	1658	1660	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:I465D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	R469P	0	.	.	1405	1407	CGT	1670	1672	CGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R469P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	R471P	0	.	.	1411	1413	CGC	1676	1678	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R471P:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	Q497R	0	.	.	1489	1491	CAG	1754	1756	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	Q497K	0	.	.	1489	1491	CAG	1754	1756	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:Q497K:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	E504Q	0	.	.	1510	1512	GAA	1775	1777	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:E504Q:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	R507G	0	.	.	1519	1521	AGG	1784	1786	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:R507G:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	G745D	0	.	.	2233	2235	GGC	2498	2500	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:G745D:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D959A	0	.	.	2875	2877	GAC	3140	3142	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D959A:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	M1000R	0	.	.	2998	3000	ATG	3263	3265	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:M1000R:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embB.3003326.AL123456.1.4246513_4249810.2078	embB.3003326.AL123456.1.4246513_4249810.2078	1	1	27	2224	embB_1	3297	3297	100.0	embB_1.l15.c30.ctg.1	3741	0.0	1	SNP	p	D1024N	0	.	.	3070	3072	GAC	3335	3337	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embB.3003326.AL123456.1.4246513_4249810.2078:1:1:D1024N:.:b'Point mutations that occur within Mycobacterium tuberculosis embB gene resulting in resistance to ethambutol.'	Mycobacterium tuberculosis embB mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	R738Q	1	R738Q	NONSYN	2212	2214	CGG	2342	2344	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R738Q:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	A247P	0	.	.	739	741	GCG	869	871	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A247P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	L251R	0	.	.	751	753	CTG	881	883	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L251R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	A254G	0	.	.	760	762	GCC	890	892	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A254G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	T270I	0	.	.	808	810	ACC	938	940	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:T270I:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	H285Y	0	.	.	853	855	CAT	983	985	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:H285Y:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	V287F	0	.	.	859	861	GTC	989	991	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V287F:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	G288W	0	.	.	862	864	GGG	992	994	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288W:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	G288V	0	.	.	862	864	GGG	992	994	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G288V:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	Y296H	0	.	.	886	888	TAC	1016	1018	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296H:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	Y296S	0	.	.	886	888	TAC	1016	1018	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y296S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	I297L	0	.	.	889	891	ATC	1019	1021	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	I297T	0	.	.	889	891	ATC	1019	1021	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:I297T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	M300R	0	.	.	898	900	ATG	1028	1030	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M300R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	R302G	0	.	.	904	906	CGG	1034	1036	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:R302G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	V303G	0	.	.	907	909	GTG	1037	1039	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V303G:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	A307T	0	.	.	919	921	GCG	1049	1051	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:A307T:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	G308D	0	.	.	922	924	GGC	1052	1054	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G308D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	Y309N	0	.	.	925	927	TAT	1055	1057	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y309N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	M310K	0	.	.	928	930	ATG	1058	1060	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:M310K:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	G325S	0	.	.	973	975	GGC	1103	1105	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:G325S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	W326R	0	.	.	976	978	TGG	1106	1108	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:W326R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	Y327N	0	.	.	979	981	TAC	1109	1111	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Y327N:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	N394D	0	.	.	1180	1182	AAC	1310	1312	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:N394D:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	P398S	0	.	.	1192	1194	CCC	1322	1324	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:P398S:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	Q491R	0	.	.	1471	1473	CAG	1601	1603	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:Q491R:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	L502P	0	.	.	1504	1506	CTC	1634	1636	CTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:L502P:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embC.3003327.CP003248.2.4240040_4243325.8264	embC.3003327.CP003248.2.4240040_4243325.8264	1	1	539	1936	embC	3285	3285	99.94	embC.l15.c4.ctg.1	3547	0.0	1	SNP	p	V981L	0	.	.	2941	2943	GTG	3071	3073	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embC.3003327.CP003248.2.4240040_4243325.8264:1:1:V981L:.:b'Point mutations in Mycobacterium tuberculosis embC that result in lower affinity between ethambutol and EmbC, resulting in resistance.'	Mycobacterium tuberculosis embC mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	868	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1458	0.0	1	SNP	p	C110Y	0	.	.	328	330	TGC	453	455	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:C110Y:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
embR.3003455.AL123456.3.1416180_1417347.4712	embR.3003455.AL123456.3.1416180_1417347.4712	1	1	27	868	embR	1167	1167	100.0	embR.l15.c4.ctg.1	1458	0.0	1	SNP	p	Q379R	0	.	.	1135	1137	CAG	1260	1262	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	embR.3003455.AL123456.3.1416180_1417347.4712:1:1:Q379R:.:b'Point mutation in the M.tuberculosis embR results in increased resistance to ethambutol.'	Mycobacterium tuberculosis embR mutant conferring resistance to ethambutol
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	P28S	0	.	.	82	84	CCG	150	152	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:P28S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	L35R	0	.	.	103	105	CTG	171	173	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L35R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	G42D	0	.	.	124	126	GGC	192	194	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:G42D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	D56Y	0	.	.	166	168	GAC	234	236	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D56Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	D58G	0	.	.	172	174	GAC	240	242	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:D58G:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	W69C	0	.	.	205	207	TGG	273	275	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:W69C:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	H102P	0	.	.	304	306	CAC	372	374	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:H102P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	Y141N	0	.	.	421	423	TAC	489	491	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Y141N:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	V179F	0	.	.	535	537	GTC	603	605	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:V179F:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	T186P	0	.	.	556	558	ACG	624	626	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T186P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	T189R	0	.	.	565	567	ACG	633	635	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:T189R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	Q246P	0	.	.	736	738	CAG	804	806	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q246P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	Q254P	0	.	.	760	762	CAG	828	830	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:Q254P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	L267V	0	.	.	799	801	CTG	867	869	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:L267V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	S329P	0	.	.	985	987	TCA	1053	1055	TCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:S329P:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	A341V	0	.	.	1021	1023	GCA	1089	1091	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A341V:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	N345K	0	.	.	1033	1035	AAC	1101	1103	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:N345K:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	A352E	0	.	.	1054	1056	GCG	1122	1124	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A352E:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	M372R	0	.	.	1114	1116	ATG	1182	1184	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:M372R:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	A395D	0	.	.	1183	1185	GCC	1251	1253	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:A395D:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	C403Y	0	.	.	1207	1209	TGT	1275	1277	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:C403Y:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
ethA.3005106.NC_000962.3.4326003_4327473.6149	ethA.3005106.NC_000962.3.4326003_4327473.6149	1	1	27	1184	ethA_2	1470	1470	100.0	ethA_2.l15.c30.ctg.1	1629	0.0	1	SNP	p	F480S	0	.	.	1438	1440	TTC	1506	1508	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	ethA.3005106.NC_000962.3.4326003_4327473.6149:1:1:F480S:.:b'Mutations in Mycobacterium tuberculosis ethA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	T20P	0	.	.	58	60	ACT	298	300	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:T20P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	E40Q	0	.	.	118	120	GAG	358	360	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40Q:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	E40G	0	.	.	118	120	GAG	358	360	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E40G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	I43S	0	.	.	127	129	ATC	367	369	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43S:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	I43T	0	.	.	127	129	ATC	367	369	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43T:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	I43A	0	.	.	127	129	ATC	367	369	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:I43A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	R49P	0	.	.	145	147	CGG	385	387	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49P:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	R49W	0	.	.	145	147	CGG	385	387	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R49W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	L56V	0	.	.	166	168	CTG	406	408	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:L56V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	R91W	0	.	.	271	273	CGG	511	513	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:R91W:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	S150G	0	.	.	448	450	AGC	688	690	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	S150C	0	.	.	448	450	AGC	688	690	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:S150C:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	E153G	0	.	.	457	459	GAG	697	699	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153G:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	E153A	0	.	.	457	459	GAG	697	699	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:E153A:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
folC.3004157.AL123456.3.2746134_2747598.5391	folC.3004157.AL123456.3.2746134_2747598.5391	1	1	27	782	folC	1464	1464	100.0	folC.l15.c4.ctg.1	1926	0.0	1	SNP	p	A420V	0	.	.	1258	1260	GCG	1498	1500	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	folC.3004157.AL123456.3.2746134_2747598.5391:1:1:A420V:.:b'Point mutations in the dihydrofolate synthetase folC gene shown clinically to confer resistance to p-aminosalicylic acid or other aminosalicylates. Mutations in folC inhibit bioactivation of PAS and thus confer resistance.'	Mycobacterium tuberculosis folC with mutation conferring resistance to para-aminosalicylic acid
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	G30R	0	.	.	88	90	GGT	261	263	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G30R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	G37V	0	.	.	109	111	GGA	282	284	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G37V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	W45C	0	.	.	133	135	TGG	306	308	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	W45S	0	.	.	133	135	TGG	306	308	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W45S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	R47Q	0	.	.	139	141	CGG	312	314	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:R47Q:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	H48Y	0	.	.	142	144	CAT	315	317	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:H48Y:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	L49F	0	.	.	145	147	CTA	318	320	CTA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L49F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	I55S	0	.	.	163	165	ATC	336	338	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:I55S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	D67H	0	.	.	199	201	GAT	372	374	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:D67H:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	S70R	0	.	.	208	210	AGC	381	383	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:S70R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	G71V	0	.	.	211	213	GGA	384	386	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G71V:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	P75S	0	.	.	223	225	CCG	396	398	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P75S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	L79S	0	.	.	235	237	TTG	408	410	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79S:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	L79F	0	.	.	235	237	TTG	408	410	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:L79F:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	P84C	0	.	.	250	252	CCG	423	425	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	P84L	0	.	.	250	252	CCG	423	425	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:P84L:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	E92A	0	.	.	274	276	GAA	447	449	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:E92A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	G117E	0	.	.	349	351	GGG	522	524	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G117E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	V124G	0	.	.	370	372	GTG	543	545	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V124G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAA	552	554	CAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:Q127P:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	A134E	0	.	.	400	402	GCG	573	575	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A134E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	A138E	0	.	.	412	414	GCG	585	587	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A138E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	588	590	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V139A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	W148R	0	.	.	442	444	TGG	615	617	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:W148R:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	G164C	0	.	.	490	492	GGC	663	665	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:G164C:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	A183E	0	.	.	547	549	GCG	720	722	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	A183T	0	.	.	547	549	GCG	720	722	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A183T:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	V188G	0	.	.	562	564	GTG	735	737	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	V188M	0	.	.	562	564	GTG	735	737	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:V188M:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gidB.3003470.AL123456.3.4407527_4408202.8134	gidB.3003470.AL123456.3.4407527_4408202.8134	1	1	27	534	gidB	675	675	99.85	gidB.l6.c17.ctg.1	1021	0.0	1	SNP	p	A200E	0	.	.	598	600	GCG	771	773	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gidB.3003470.AL123456.3.4407527_4408202.8134:1:1:A200E:.:b'Specific mutations that occurs on Mycobacterium tuberculosis gidB causing it to be streptomycin resistant.'	Mycobacterium tuberculosis gidB mutation conferring resistance to streptomycin
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	0	.	p	.	0	E21Q	NONSYN	61	63	GAG	264	266	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	0	.	p	.	0	S95T	NONSYN	283	285	AGC	486	488	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	0	.	p	.	0	G668D	NONSYN	2002	2004	GGC	2205	2207	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	A74S	0	.	.	220	222	GCC	423	425	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A74S:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	T80A	0	.	.	238	240	ACC	441	443	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:T80A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	G88A	0	.	.	262	264	GGC	465	467	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	G88C	0	.	.	262	264	GGC	465	467	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:G88C:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D89V	0	.	.	265	267	GAC	468	470	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D89G	0	.	.	265	267	GAC	468	470	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D89N	0	.	.	265	267	GAC	468	470	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D89N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	A90V	0	.	.	268	270	GCG	471	473	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	A90G	0	.	.	268	270	GCG	471	473	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:A90G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	S91P	0	.	.	271	273	TCG	474	476	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:S91P:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D94Y	0	.	.	280	282	GAC	483	485	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94Y:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D94N	0	.	.	280	282	GAC	483	485	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94N:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D94G	0	.	.	280	282	GAC	483	485	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94G:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D94V	0	.	.	280	282	GAC	483	485	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94V:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D94T	0	.	.	280	282	GAC	483	485	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94T:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	D94A	0	.	.	280	282	GAC	483	485	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:D94A:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrA.3003295.AL123456.1.7301_9818.2055	gyrA.3003295.AL123456.1.7301_9818.2055	1	1	539	1812	gyrA_1	2517	2517	99.88	gyrA_1.l15.c17.ctg.1	2843	0.0	1	SNP	p	P102H	0	.	.	304	306	CCC	507	509	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrA.3003295.AL123456.1.7301_9818.2055:1:1:P102H:.:b'Point mutation of Mycobacterium tuberculosis gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance.'	Mycobacterium tuberculosis gyrA conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	V340L	0	.	.	1018	1020	GTG	1250	1252	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:V340L:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	D500H	0	.	.	1498	1500	GAC	1730	1732	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:D500H:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	N538K	0	.	.	1612	1614	AAC	1844	1846	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538K:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	N538D	0	.	.	1612	1614	AAC	1844	1846	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:N538D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	T539N	0	.	.	1615	1617	ACC	1847	1849	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539N:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	T539P	0	.	.	1615	1617	ACC	1847	1849	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:T539P:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	E540V	0	.	.	1618	1620	GAA	1850	1852	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540V:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
gyrB.3003459.X78888.1.300_2445.5872	gyrB.3003459.X78888.1.300_2445.5872	1	1	27	1704	gyrB_6	2145	2145	99.95	gyrB_6.l15.c17.ctg.1	2560	0.0	1	SNP	p	E540D	0	.	.	1618	1620	GAA	1850	1852	GAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	gyrB.3003459.X78888.1.300_2445.5872:1:1:E540D:.:b'Point mutation in Mycobacterium tuberculosis gyrB resulting in fluoroquinolone resistance.'	Mycobacterium tuberculosis gyrB mutant conferring resistance to fluoroquinolones
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	I16T	0	.	.	46	48	ATC	304	306	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I16T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	I21T	0	.	.	61	63	ATC	319	321	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	I21V	0	.	.	61	63	ATC	319	321	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I21V:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	I47T	0	.	.	139	141	ATT	397	399	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I47T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	V78A	0	.	.	232	234	GTG	490	492	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:V78A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	S94A	0	.	.	280	282	TCG	538	540	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:S94A:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	I95P	0	.	.	283	285	ATT	541	543	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I95P:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	G141E	0	.	.	421	423	GGA	679	681	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:G141E:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
inhA.3003393.AL123456.1.1674201_1675011.2085	inhA.3003393.AL123456.1.1674201_1675011.2085	1	1	27	476	inhA	810	810	100.0	inhA.l6.c30.ctg.1	1247	0.0	1	SNP	p	I194T	0	.	.	580	582	ATC	838	840	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	inhA.3003393.AL123456.1.1674201_1675011.2085:1:1:I194T:.:b'inhA is a enoyl-acyl carrier reductase used in lipid metabolism and farry acid biosynthesis. It is inhibited by isoniazid. mutations in the promoter region or multiple copies of the inhA shows marked resistance to isoniazid mediated inhibition of mycolic acid biosynthesis.'	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1390	iniA	1923	1923	100.0	iniA.l15.c30.ctg.1	2513	0.0	1	SNP	p	P3A	0	.	.	7	9	CCC	320	322	CCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:P3A:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1390	iniA	1923	1923	100.0	iniA.l15.c30.ctg.1	2513	0.0	1	SNP	p	G308R	0	.	.	922	924	GGG	1235	1237	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:G308R:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1390	iniA	1923	1923	100.0	iniA.l15.c30.ctg.1	2513	0.0	1	SNP	p	S501W	0	.	.	1501	1503	TCG	1814	1816	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:S501W:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniA.3003448.AL123456.1.410837_412760.2099	iniA.3003448.AL123456.1.410837_412760.2099	1	1	27	1390	iniA	1923	1923	100.0	iniA.l15.c30.ctg.1	2513	0.0	1	SNP	p	R537H	0	.	.	1609	1611	CGC	1922	1924	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniA.3003448.AL123456.1.410837_412760.2099:1:1:R537H:.:b'Specific mutations in Mycobacterium tuberculosis iniA resulting in resistance to ethambutol.'	Mycobacterium tuberculosis iniA mutant conferring resistance to ethambutol
iniB.3004135.AL123456.3.409361_410801.5509	iniB.3004135.AL123456.3.409361_410801.5509	1	1	27	704	iniB	1440	1440	100.0	iniB.l6.c4.ctg.1	1711	0.0	1	SNP	p	A47T	0	.	.	139	141	GCC	327	329	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniB.3004135.AL123456.3.409361_410801.5509:1:1:A47T:.:b'Point mutations in M. tuberculosis iniB shown to confer resistance to ethambutol.'	Mycobacterium tuberculosis iniB with mutation conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	892	iniC	1482	1482	99.93	iniC.l15.c4.ctg.1	1935	0.0	1	SNP	p	W83G	0	.	.	247	249	TGG	481	483	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:W83G:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
iniC.3003451.AL123456.1.412756_414238.2100	iniC.3003451.AL123456.1.412756_414238.2100	1	1	27	892	iniC	1482	1482	99.93	iniC.l15.c4.ctg.1	1935	0.0	1	SNP	p	P248A	0	.	.	742	744	CCG	976	978	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	iniC.3003451.AL123456.1.412756_414238.2100:1:1:P248A:.:b'Specific mutations that occurs on Mycobacterium tuberculosis iniC causing it to be ethambutol resistant.'	Mycobacterium tuberculosis iniC mutant conferring resistance to ethambutol
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	526	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1600	0.0	1	SNP	p	D66N	0	.	.	196	198	GAT	374	376	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:D66N:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	526	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1600	0.0	1	SNP	p	R121K	0	.	.	361	363	AGG	539	541	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:R121K:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	526	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1600	0.0	1	SNP	p	G269S	0	.	.	805	807	GGT	983	985	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G269S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	526	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1600	0.0	1	SNP	p	G312S	0	.	.	934	936	GGC	1112	1114	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G312S:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	526	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1600	0.0	1	SNP	p	G387D	0	.	.	1159	1161	GGC	1337	1339	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:G387D:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
kasA.3003463.AL123456.1.2518114_2519365.2084	kasA.3003463.AL123456.1.2518114_2519365.2084	1	1	27	526	kasA	1251	1251	100.0	kasA.l15.c4.ctg.1	1600	0.0	1	SNP	p	F413L	0	.	.	1237	1239	TTC	1415	1417	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	kasA.3003463.AL123456.1.2518114_2519365.2084:1:1:F413L:.:b'Specific mutations on the Mycobacterium tuberculosis kasA gene resulting in lowered affinity of isoniazid, resulting in resistance.'	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	0	.	p	.	0	R463L	NONSYN	1387	1389	CGG	1691	1693	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	.	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	G33V	0	.	.	97	99	GGC	401	403	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G33V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	W91R	0	.	.	271	273	TGG	575	577	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:W91R:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	A110V	0	.	.	328	330	GCC	632	634	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A110V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	G111S	0	.	.	331	333	GGC	635	637	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G111S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	G125S	0	.	.	373	375	GGC	677	679	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G125S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	M126I	0	.	.	376	378	ATG	680	682	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:M126I:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	Q127P	0	.	.	379	381	CAG	683	685	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q127P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	D142G	0	.	.	424	426	GAC	728	730	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:D142G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	L147P	0	.	.	439	441	CTG	743	745	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:L147P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	A264V	0	.	.	790	792	GCG	1094	1096	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A264V:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	A312P	0	.	.	934	936	GCG	1238	1240	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:A312P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	S315T	0	.	.	943	945	AGC	1247	1249	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315T:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	S315N	0	.	.	943	945	AGC	1247	1249	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315N:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	S315G	0	.	.	943	945	AGC	1247	1249	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:S315G:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	H417Q	0	.	.	1249	1251	CAC	1553	1555	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:H417Q:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	Q461P	0	.	.	1381	1383	CAG	1685	1687	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:Q461P:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	G490S	0	.	.	1468	1470	GGC	1772	1774	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:G490S:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	N508D	0	.	.	1522	1524	AAC	1826	1828	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N508D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	E607A	0	.	.	1819	1821	GAG	2123	2125	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:E607A:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
katG.3005102.AL123456.3.2153888_2156111.6146	katG.3005102.AL123456.3.2153888_2156111.6146	1	1	539	2356	katG_1	2223	2223	99.96	katG_1.l15.c4.ctg.1	2789	0.0	1	SNP	p	N660D	0	.	.	1978	1980	AAC	2282	2284	AAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	katG.3005102.AL123456.3.2153888_2156111.6146:1:1:N660D:.:b'Mutations in Mycobacterium tuberculosis katG conferring resistance to prothionamide, an analogue of isoniazid.'	Mycobacterium tuberculosis katG mutations conferring resistance to prothionamide
mfpA.3003035.AL123456.1.3773015_3773567.4588	mfpA.3003035.AL123456.1.3773015_3773567.4588	1	0	27	402	mfpA	552	552	100.0	mfpA.l6.c30.ctg.1	1010	0.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfpA;b'mfpA is a qnr homolog and a pentapeptide repeat protein that confers resistance to fluoroquinolones in Mycolicibacterium smegmatis.'
mshA.3005108.NC_000962.3.575347_576790.6150	mshA.3005108.NC_000962.3.575347_576790.6150	1	1	27	766	mshA_1	1443	1443	100.0	mshA_1.l15.c4.ctg.1	1916	0.0	1	SNP	p	F355S	0	.	.	1063	1065	TTC	1309	1311	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	mshA.3005108.NC_000962.3.575347_576790.6150:1:1:F355S:.:b'Mutations in Mycobacterium tuberculosis mshA conferring resistance to prothionamide, an analogue to isoniazid.'	Mycobacterium tuberculosis mshA mutations conferring resistance to prothionamide
murA.3003784.HE608151.1.1472985_1474242.3555	murA.3003784.HE608151.1.1472985_1474242.3555	1	1	27	978	murA_4	1257	1257	100.0	murA_4.l15.c17.ctg.1	1469	0.0	1	SNP	p	C117D	1	.	.	349	351	GAC	429	431	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	murA.3003784.HE608151.1.1472985_1474242.3555:1:1:C117D:.:b'Mycobacterium tuberculosis murA confers intrinsic resistance to fosfomycin. The presence of an aspartic acid residue in place of the critical cysteine at position 117 that enables fosfomycin binding is believed to be responsible for this intrinsic resistance.'	Mycobacterium tuberculosis intrinsic murA conferring resistance to fosfomycin
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	M1S	0	.	.	1	3	ATG	201	203	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M1S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A3E	0	.	.	7	9	GCG	207	209	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A3E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L4W	0	.	.	10	12	TTG	210	212	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L4W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	I5S	0	.	.	13	15	ATC	213	215	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I5S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V7F	0	.	.	19	21	GTC	219	221	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V7G	0	.	.	19	21	GTC	219	221	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V7D	0	.	.	19	21	GTC	219	221	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V7D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D8Y	0	.	.	22	24	GAC	222	224	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D8Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V9G	0	.	.	25	27	GTG	225	227	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V9A	0	.	.	25	27	GTG	225	227	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V9A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Q10K	0	.	.	28	30	CAG	228	230	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Q10R	0	.	.	28	30	CAG	228	230	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Q10P	0	.	.	28	30	CAG	228	230	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q10P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D12E	0	.	.	34	36	GAC	234	236	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D12N	0	.	.	34	36	GAC	234	236	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D12A	0	.	.	34	36	GAC	234	236	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D12A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C14Y	0	.	.	40	42	TGC	240	242	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C14R	0	.	.	40	42	TGC	240	242	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C14R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	G17S	0	.	.	49	51	GGC	249	251	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	G17D	0	.	.	49	51	GGC	249	251	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G17D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L19P	0	.	.	55	57	CTG	255	257	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L19P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	G23V	0	.	.	67	69	GGT	267	269	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G23V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A26G	0	.	.	76	78	GCG	276	278	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A26G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L27P	0	.	.	79	81	CTG	279	281	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L27P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Y34S	0	.	.	100	102	TAC	300	302	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y34S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Y41H	0	.	.	121	123	TAC	321	323	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y41H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V45G	0	.	.	133	135	GTG	333	335	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V45G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A46E	0	.	.	136	138	GCA	336	338	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A46V	0	.	.	136	138	GCA	336	338	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A46V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T47S	0	.	.	139	141	ACC	339	341	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T47P	0	.	.	139	141	ACC	339	341	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T47A	0	.	.	139	141	ACC	339	341	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T47A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D49V	0	.	.	145	147	GAC	345	347	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D49A	0	.	.	145	147	GAC	345	347	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D49A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H51Q	0	.	.	151	153	CAC	351	353	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H51Y	0	.	.	151	153	CAC	351	353	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H51Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D53A	0	.	.	157	159	GAC	357	359	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D53A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	P54T	0	.	.	160	162	CCG	360	362	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	P54L	0	.	.	160	162	CCG	360	362	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P54L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H57D	0	.	.	169	171	CAC	369	371	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H57Q	0	.	.	169	171	CAC	369	371	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H57Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	F58L	0	.	.	172	174	TTC	372	374	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F58L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	P62H	0	.	.	184	186	CCG	384	386	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P62H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	S66P	0	.	.	196	198	TCG	396	398	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S66P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	S67P	0	.	.	199	201	TCG	399	401	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S67P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	W68G	0	.	.	202	204	TGG	402	404	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	W68L	0	.	.	202	204	TGG	402	404	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	W68C	0	.	.	202	204	TGG	402	404	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	W68R	0	.	.	202	204	TGG	402	404	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	W68S	0	.	.	202	204	TGG	402	404	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W68S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	P69R	0	.	.	205	207	CCA	405	407	CCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:P69R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H71E	0	.	.	211	213	CAT	411	413	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H71E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C72W	0	.	.	214	216	TGC	414	416	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C72R	0	.	.	214	216	TGC	414	416	TGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C72R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T76I	0	.	.	226	228	ACT	426	428	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76I:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T76P	0	.	.	226	228	ACT	426	428	ACT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T76P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	G78D	0	.	.	232	234	GGC	432	434	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G78D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H82R	0	.	.	244	246	CAT	444	446	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H82R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L85R	0	.	.	253	255	CTG	453	455	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L85P	0	.	.	253	255	CTG	453	455	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L85P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	I90S	0	.	.	268	270	ATC	468	470	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I90S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	F94P	0	.	.	280	282	TTC	480	482	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:F94P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	K96M	0	.	.	286	288	AAG	486	488	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	K96Q	0	.	.	286	288	AAG	486	488	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96Q:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	K96N	0	.	.	286	288	AAG	486	488	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	K96E	0	.	.	286	288	AAG	486	488	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:K96E:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	G97S	0	.	.	289	291	GGT	489	491	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G97S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T100P	0	.	.	298	300	ACC	498	500	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T100P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A102T	0	.	.	304	306	GCG	504	506	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A102V	0	.	.	304	306	GCG	504	506	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A102V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Y103S	0	.	.	307	309	TAC	507	509	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Y103H	0	.	.	307	309	TAC	507	509	TAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Y103H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	S104C	0	.	.	310	312	AGC	510	512	AGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S104C:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L116R	0	.	.	346	348	CTG	546	548	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L116R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	N118T	0	.	.	352	354	AAT	552	554	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:N118T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	W119R	0	.	.	355	357	TGG	555	557	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:W119R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	R121P	0	.	.	361	363	CGG	561	563	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R121P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V125D	0	.	.	373	375	GTC	573	575	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V125D:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	G132S	0	.	.	394	396	GGT	594	596	GGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:G132S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	I133T	0	.	.	397	399	ATT	597	599	ATT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:I133T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A134V	0	.	.	400	402	GCC	600	602	GCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A134V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T135P	0	.	.	403	405	ACC	603	605	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T135P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D136N	0	.	.	406	408	GAT	606	608	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D136Y	0	.	.	406	408	GAT	606	608	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	D136H	0	.	.	406	408	GAT	606	608	GAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:D136H:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H137R	0	.	.	409	411	CAT	609	611	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	H137P	0	.	.	409	411	CAT	609	611	CAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:H137P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C138Y	0	.	.	412	414	TGT	612	614	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138Y:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C138S	0	.	.	412	414	TGT	612	614	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	C138W	0	.	.	412	414	TGT	612	614	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:C138W:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V139M	0	.	.	415	417	GTG	615	617	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V139L	0	.	.	415	417	GTG	615	617	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139L:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V139A	0	.	.	415	417	GTG	615	617	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V139A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	R140G	0	.	.	418	420	CGC	618	620	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R140G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	Q141P	0	.	.	421	423	CAG	621	623	CAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:Q141P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T142K	0	.	.	424	426	ACG	624	626	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142K:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T142M	0	.	.	424	426	ACG	624	626	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T142M:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A146T	0	.	.	436	438	GCG	636	638	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A146T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	R154G	0	.	.	460	462	AGG	660	662	AGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:R154G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V155G	0	.	.	463	465	GTG	663	665	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V155G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V157G	0	.	.	469	471	GTG	669	671	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V157G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L159R	0	.	.	475	477	CTG	675	677	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L159R:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T160P	0	.	.	478	480	ACA	678	680	ACA	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T160P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A161G	0	.	.	481	483	GCG	681	683	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A161P	0	.	.	481	483	GCG	681	683	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A161P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	S164P	0	.	.	490	492	TCG	690	692	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:S164P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	T168N	0	.	.	502	504	ACC	702	704	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:T168N:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A171P	0	.	.	511	513	GCG	711	713	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A171T	0	.	.	511	513	GCG	711	713	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171T:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	A171V	0	.	.	511	513	GCG	711	713	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:A171V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L172A	0	.	.	514	516	CTG	714	716	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172A:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L172P	0	.	.	514	516	CTG	714	716	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L172P:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	E174G	0	.	.	520	522	GAG	720	722	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:E174G:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	M175V	0	.	.	523	525	ATG	723	725	ATG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:M175V:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	V180F	0	.	.	538	540	GTC	738	740	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:V180F:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
pncA.3003394.AL123456.1.2288680_2289241.4593	pncA.3003394.AL123456.1.2288680_2289241.4593	1	1	27	374	pncA	561	561	99.82	pncA.l15.c17.ctg.1	944	0.0	1	SNP	p	L182S	0	.	.	544	546	TTG	744	746	TTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	pncA.3003394.AL123456.1.2288680_2289241.4593:1:1:L182S:.:b'pncA is a pyrazinamidase/nicotinamidase. It catalyzes the activation of pyrazinamide. Some mutation within pncA are associated with loss of enzyme activity, resulting in pyrazinamide resistance.'	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide
ribD.3004184.AL123456.3.2986838_2987615.5511	ribD.3004184.AL123456.3.2986838_2987615.5511	1	1	27	476	ribD	777	777	100.0	ribD.l15.c17.ctg.1	1098	0.0	1	SNP	p	G8R	0	.	.	22	24	GGA	188	190	GGA	ND;ND;ND	ND;ND;ND	ND;ND;ND	ribD.3004184.AL123456.3.2986838_2987615.5511:1:1:G8R:.:b'ribD is a Mycobacterium tuberculosis riboflavin biosynthesis enzyme. Point mutations in ribD cause enzyme overexpression, which allows the C-terminal reductase domain to act as an alternative dihydrofolate reductase. Thus, mutations in ribD confer resistance to DHFR inhibitors such as para-aminosalicylic acid.'	Mycobacterium tuberculosis ribD with mutation conferring resistance to para-aminosalicylic acid
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	V146F	0	.	.	436	438	GTG	609	611	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:V146F:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	S450L	0	.	.	1348	1350	TCG	1521	1523	TCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:S450L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	F505L	0	.	.	1513	1515	TTC	1686	1688	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:F505L:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	T508N	0	.	.	1522	1524	ACG	1695	1697	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508N:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	T508P	0	.	.	1522	1524	ACG	1695	1697	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508P:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	T508A	0	.	.	1522	1524	ACG	1695	1697	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508A:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	T508H	0	.	.	1522	1524	ACG	1695	1697	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508H:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	T508S	0	.	.	1522	1524	ACG	1695	1697	ACG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:T508S:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	L511R	1	.	.	1531	1533	CGC	1704	1706	CGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:L511R:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	D516G	1	.	.	1546	1548	GGC	1719	1721	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:D516G:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpoB.3003283.AL123456.3.759806_763325.4199	rpoB.3003283.AL123456.3.759806_763325.4199	1	1	27	2250	rpoB_1	3519	3519	99.94	rpoB_1.l15.c4.ctg.1	3868	0.0	1	SNP	p	H526T	1	.	.	1576	1578	ACC	1749	1751	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpoB.3003283.AL123456.3.759806_763325.4199:1:1:H526T:.:b'Point mutations that occurs in Mycobacterium tuberculosis rpoB resulting in resistance to rifampicin.'	Mycobacterium tuberculosis rpoB mutants conferring resistance to rifampicin
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	D123A	0	.	.	367	369	GAC	531	533	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D123A:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	S324F	0	.	.	970	972	TCC	1134	1136	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:S324F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	E325K	0	.	.	973	975	GAG	1137	1139	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:E325K:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	G341R	0	.	.	1021	1023	GGC	1185	1187	GGC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:G341R:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	D342N	0	.	.	1024	1026	GAC	1188	1190	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D342N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	D343N	0	.	.	1027	1029	GAC	1191	1193	GAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:D343N:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	A344P	0	.	.	1030	1032	GCG	1194	1196	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:A344P:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsA.3004721.AL123456.3.1833541_1834987.5598	rpsA.3004721.AL123456.3.1833541_1834987.5598	1	1	27	938	rpsA	1446	1446	100.0	rpsA.l15.c4.ctg.1	1830	0.0	1	SNP	p	I351F	0	.	.	1051	1053	ATC	1215	1217	ATC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsA.3004721.AL123456.3.1833541_1834987.5598:1:1:I351F:.:b'RpsA, the 30S ribosomal protein S1 of Mycobacterium tuberculosis, is involved in trans-translation and is targeted by pyrazinonic acid, the active form of the antibiotic pyrazinamide, which disrupts the initiation of mRNA translation. Mutations in the amino acid sequence of rpsA can confer resistance to pyrazinamide maintaining rpsA function.'	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	316	rpsL	375	375	100.0	rpsL.l6.c30.ctg.1	829	0.0	1	SNP	p	T40I	0	.	.	118	120	ACC	300	302	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:T40I:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	316	rpsL	375	375	100.0	rpsL.l6.c30.ctg.1	829	0.0	1	SNP	p	K43R	0	.	.	127	129	AAG	309	311	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K43R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	316	rpsL	375	375	100.0	rpsL.l6.c30.ctg.1	829	0.0	1	SNP	p	K88Q	0	.	.	262	264	AAG	444	446	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88Q:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rpsL.3003395.AE000516.1.783533_783908.2087	rpsL.3003395.AE000516.1.783533_783908.2087	1	1	27	316	rpsL	375	375	100.0	rpsL.l6.c30.ctg.1	829	0.0	1	SNP	p	K88R	0	.	.	262	264	AAG	444	446	AAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	rpsL.3003395.AE000516.1.783533_783908.2087:1:1:K88R:.:b'Ribosomal protein S12 stabilizes the highly conserved pseudoknot structure formed by 16S rRNA. Amino acid substitutions in RpsL affect the higher-order structure of 16S rRNA and confer streptomycin resistance by disrupting interactions between 16S rRNA and streptomycin.'	Mycobacterium tuberculosis rpsL mutations conferring resistance to Streptomycin
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	T1076A	SNP	1076	1076	T	44	44	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	T1207C	SNP	1207	1207	T	175	175	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	G1214A	SNP	1214	1214	G	182	182	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	T1224.	DEL	1224	1224	T	191	191	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	C1227A	SNP	1227	1227	C	194	194	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	G1380A	SNP	1380	1380	G	347	347	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	T1394C	SNP	1394	1394	T	361	361	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	T1396.	DEL	1396	1396	T	362	362	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	0	.	n	.	0	C1406T	SNP	1406	1406	C	372	372	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003540.X52922.1.0_1454.4148	rrsB.3003540.X52922.1.0_1454.4148	0	0	528	32	rrsB_9	1454	422	97.63	rrsB_9.l15.c30.ctg.1	484	0.0	1	SNP	n	C1439U	0	.	.	1439	1439	C	405	405	C	ND	ND	ND	rrsB.3003540.X52922.1.0_1454.4148:0:0:C1439U:.:b'Point mutations in the highly conserved helix 44 of the 16S rrsB rRNA gene of Mycolicibacterium smegmatis can confer resistance to hygromycin B. Resistance against hygromycin B is the result of conformational alterations that distorts a strong hydrogen bond leading to a change in the local geometry of the hygromycin B binding site.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to hygromycin B
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	T1117A	SNP	1117	1117	T	44	44	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	T1248C	SNP	1248	1248	T	175	175	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	G1254T	SNP	1254	1254	G	181	181	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	G1255A	SNP	1255	1255	G	182	182	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	T1265.	DEL	1265	1265	T	191	191	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	C1268A	SNP	1268	1268	C	194	194	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	G1421A	SNP	1421	1421	G	347	347	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	T1437.	DEL	1437	1437	T	362	362	G	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	0	.	n	.	0	C1447T	SNP	1447	1447	C	372	372	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	1	SNP	n	G1475U	0	.	.	1475	1475	G	400	400	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475U:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	455	97.8	rrsB_13.l15.c4.ctg.1	621	0.0	1	SNP	n	G1475A	0	.	.	1475	1475	G	400	400	G	ND	ND	ND	rrsB.3003547.NC_008596.1.5027948_5029475.3248:0:0:G1475A:.:b'Point mutations in the helix 44 region of the 16S rRNA rrsB gene of Mycolicibacterium smegmatis can confer resistance to viomycin.'	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	171	96.49	rrsB_13.l15.c4.ctg.2	400	0.0	0	.	n	.	0	C81T	SNP	81	81	C	309	309	T	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	171	96.49	rrsB_13.l15.c4.ctg.2	400	0.0	0	.	n	.	0	T82C	SNP	82	82	T	310	310	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	171	96.49	rrsB_13.l15.c4.ctg.2	400	0.0	0	.	n	.	0	G90A	SNP	90	90	G	318	318	A	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
rrsB.3003547.NC_008596.1.5027948_5029475.3248	rrsB.3003547.NC_008596.1.5027948_5029475.3248	0	0	512	60	rrsB_13	1528	171	96.49	rrsB_13.l15.c4.ctg.2	400	0.0	0	.	n	.	0	T142C	SNP	142	142	T	370	370	C	ND	ND	ND	.	Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	T22A	0	.	.	64	66	ACC	218	220	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T22A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	Y36C	0	.	.	106	108	TAT	260	262	TAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:Y36C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	H75N	0	.	.	223	225	CAC	377	379	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H75N:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	V77F	0	.	.	229	231	GTC	383	385	GTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:V77F:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	W83C	0	.	.	247	249	TGG	401	403	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W83C:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	G91R	0	.	.	271	273	GGG	425	427	GGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:G91R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	W101R	0	.	.	301	303	TGG	455	457	TGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:W101R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	S105P	0	.	.	313	315	TCC	467	469	TCC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:S105P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	R126Q	0	.	.	376	378	CGG	530	532	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R126Q:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	F152V	0	.	.	454	456	TTC	608	610	TTC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:F152V:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	C161T	0	.	.	481	483	TGT	635	637	TGT	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:C161T:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	T202A	0	.	.	604	606	ACC	758	760	ACC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:T202A:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	H207R	0	.	.	619	621	CAC	773	775	CAC	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:H207R:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	P224L	0	.	.	670	672	CCG	824	826	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:P224L:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
thyA.3004153.AL123456.3.3073679_3074471.5390	thyA.3004153.AL123456.3.3073679_3074471.5390	1	1	27	574	thyA	792	792	100.0	thyA.l15.c4.ctg.1	1156	0.0	1	SNP	p	R235P	0	.	.	703	705	CGG	857	859	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	thyA.3004153.AL123456.3.3073679_3074471.5390:1:1:R235P:.:b'Point mutations in the thymidylate synthetase thyA gene shown clinically to confer resistance to para-aminosalicylic acid. Loss-of-function mutations in thyA disrupt the catalytic activity and substrate-binding affinity, thus conferring resistance.'	Mycobacterium tuberculosis thyA with mutation conferring resistance to para-aminosalicylic acid
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	R14W	0	.	.	40	42	CGG	184	186	CGG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:R14W:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	A67E	0	.	.	199	201	GCG	343	345	GCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A67E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	K69E	0	.	.	205	207	AAA	349	351	AAA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:K69E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	A91E	0	.	.	271	273	GCA	415	417	GCA	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:A91E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	L118P	0	.	.	352	354	CTG	496	498	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L118P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	V128E	0	.	.	382	384	GTG	526	528	GTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:V128E:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	L150P	0	.	.	448	450	CTG	592	594	CTG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:L150P:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	P183L	0	.	.	547	549	CCG	691	693	CCG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:P183L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	F185L	0	.	.	553	555	TTT	697	699	TTT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:F185L:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	N236K	0	.	.	706	708	AAT	850	852	AAT	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:N236K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
tlyA.3003445.AE000516.1.1908741_1909548.2076	tlyA.3003445.AE000516.1.1908741_1909548.2076	1	1	27	506	tlyA	807	807	99.88	tlyA.l15.c17.ctg.1	1175	0.0	1	SNP	p	E238K	0	.	.	712	714	GAG	856	858	GAG	ND;ND;ND	ND;ND;ND	ND;ND;ND	tlyA.3003445.AE000516.1.1908741_1909548.2076:1:1:E238K:.:b'Specific mutations that arise in Mycobacterium tuberculosis tlyA resulting in aminoglycosides resistance.'	Mycobacterium tuberculosis tlyA mutations conferring resistance to aminoglycosides
